Background: Rhinoplasty remains one of the most common aesthetic procedures performed in the United States. Current literature on rhinoplasty complications is inconclusive and is based on retrospective reviews and small cohorts. Objectives: The purpose of this study was to examine the incidence and identify predictive risk factors for major complications following rhinoplasty alone or in combination with other aesthetic operations in a large, prospective, multicenter database study. Methods: A prospective cohort of patients undergoing rhinoplasty between May 2008 and May 2013 was identified from the CosmetAssure database. Primary outcome was occurrence of major complications, defined as complications requiring an emergency room visit, hospital admission, or a reoperation within 30 days of the index operation. Univariate and multivariate analysis evaluated potential risk factors for major complications including age, gender, body mass index (BMI), smoking, diabetes, type of surgical facility, and combined procedures. Results: A total of 129,007 patients were identified, of which 4978 (3.9%) underwent a rhinoplasty. The overall complication rate was 0.7% (n = 37). Hematoma was the most common complication (0.2%), followed by infection (0.2%), and pulmonary complications (0.1%). Age ≥40 years was found to be an independent risk factor for developing complications. Age ≥40 years was found to have a relative risk of 2.05 (P = 0.04) for any major complication. Complications increased from 0.58% in rhinoplasty alone cases to 1.02% (P < 0.05) with the addition of 1 other body region to 2.09% with the addition of 2 other body regions (P < 0.05). The risk of pulmonary complications increased from 0.1% to 1% (P < 0.05) with the addition of rhinoplasty with 2 other body regions. Gender, type of facility, smoking status, and BMI ≥25 did not appear to significantly impact the risk for major complications. Conclusions: The major complication rate following rhinoplasty remains low. The risk is increased with age ≥40 years and with the addition of other cosmetic procedures. Pulmonary complications, although rare, do occur, and also increase when combining rhinoplasty with other aesthetic surgery. These findings are important to consider when planning rhinoplasty and educating patients on the safety of combined aesthetic surgeries.
Rhinoplasty continues to be one of the most challenging operations in plastic surgery. With little margin for error, precise techniques are essential for an excellent functional and aesthetic outcome. [1] [2] [3] [4] Despite its complexity, rhinoplasty remains one of the most common aesthetic operations performed by plastic surgeons both in the United States and globally. In the United States, rhinoplasty ranked as the fifth most common cosmetic surgical procedure with over 145,000 rhinoplasties performed in 2014, an increase of 6.5% since 1997. 5 Globally, rhinoplasty also ranks as the fifth most common aesthetic surgery, with close to 850,000 performed in 2014. 6 Rhinoplasty has evolved to comprise multiple techniques specifically suited to accomplish precise goals and to avoid complications. [7] [8] [9] Although the overall incidence of major complications is low, any complication can have a significant impact on final cosmetic and functional outcomes, as well as being a financial burden to the patient and surgeon. Types of complications include hemorrhagic (epistaxis, septal hematoma), infectious, traumatic, functional, aesthetic, and soft-tissue related etiologies. 3 There is a paucity of literature documenting rhinoplasty complication rates and preoperative risk factors. The reported incidence of significant complications following rhinoplasty ranges widely from 1.7% to 18%. 3, [10] [11] [12] [13] [14] [15] The most common complications include infection (0%-15%), excessive epistaxis (0.5%-2%), incisional dehiscence (5%), and patient dissatisfaction (15%-17%). A variety of risk factors have been linked to these complications with variable supporting evidence. The current literature is limited by small cohorts, retrospective reviews and single center experiences. [10] [11] [12] [13] [14] [15] [16] [17] The objectives of this study are to use CosmetAssure (Aesthetic Surgeons' Financial Group, Birmingham, AL), a large, prospective, multicenter insurance database to determine the incidence and types of complications following rhinoplasty, and to identify the risk factors associated with significant complications.
METHODS

Study Population
This prospective cohort study was approved by the Institutional Review Board at Vanderbilt University (Reference number 140082). The study population comprised of a cohort of patients who enrolled into the CosmetAssure insurance program and underwent cosmetic surgical procedure(s) between May 2008 and May 2013. The CosmetAssure database was accessed in February 2014 following approval by the Institutional Review Board.
Database
CosmetAssure is an insurance program that covers the cost of unexpected major complications from 24 covered cosmetic surgical procedures, which may not be reimbursed by the patient's primary insurer. CosmetAssure was introduced in 2003 and has been prospectively collecting risk factor data for research purposes since 2008. This insurance program covers all 50 states in the United States. It is available to American Board of Plastic Surgery (ABPS)-certified plastic surgeons and is endorsed by the American Society of Plastic Surgeons (ASPS). The program is also available to ASPS Candidates for Membership who have passed the ABPS Written Examination. Every patient undergoing any covered procedure at participating practices is required to enroll in the program. Patients' demographics and risk factor information are entered into the database prior to undergoing the procedure, thus making it a prospective cohort. Surgeon-reported major complications, filed as a claim, are recorded in the database. Personnel employed by CosmetAssure enter data provided by the surgeon at the time of patient enrollment, as well as any claims filed by the surgeon. CosmetAssure, being a private insurance company, has a vested interest in maintaining an accurate database for actuarial and audit purposes. Major complication is defined as that occurring within 30 days of the operation that requires emergency room visit, hospital admission, or reoperation. This excludes complications that can be managed in clinic, including minor wound infections and seromas, as they are not applicable for insurance claims. The covered major complications include hematoma, infection, pulmonary dysfunction, cardiac complication, wound-related problems, suspected or confirmed venous thromboembolism (VTE), myocardial infarction, and fluid overload. Other major complications (nerve injury, urinary retention etc.) have been reported to CosmetAssure but may not qualify for expense reimbursement. The database lists all procedures performed on the patient, making it possible to study specific individual procedures as well as procedure combinations (ie, patients undergoing multiple procedures under the same anesthetic). The database also records demographic and comorbidity data including age, gender, body mass index (BMI), smoking, diabetes mellitus, and type of surgical facility (office-based surgical suites (OBSS), accredited surgical centers (ASC), and hospitals).
Exposure
In this study, primary exposure was defined as rhinoplasty regardless of whether it was performed individually or in combination with other face procedures (including brow lifts, blepharoplasty, cheek implant, chin augmentation, facial resurfacing, hair replacement, otoplasty, facelift), body procedures (abdominoplasty, brachioplasty, buttock lift, calf implant, labiaplasty, liposuction, lower body lift, thigh lift, upper body lift), and/or breast procedures (augmentation, reduction, revisional breast implant procedures, mastopexy, male breast surgery). Patients who underwent more than one procedure under the same anesthetic were considered to have combined procedures.
Outcome and Risk Factors
In this study, primary outcome was the occurrence of any major complication(s), as defined above, within 30 days of the rhinoplasty. The type of complication was the secondary outcome studied. The risk factors evaluated in this cohort included age, gender, BMI, smoking status, diabetes mellitus, type of facility (OBSS, ASC, hospital), and combinations of procedures as defined above.
Demographic Variables and Surgical Procedures
Distribution of factors including age, gender, BMI, smoking, diabetes mellitus, type of surgical facility, and combined procedures were compared between patients with and without a diagnosed major complication. The dataset included 24 unique cosmetic surgical procedures, and patients underwent anywhere from 1 to 7 procedures, resulting in more than 700 procedure combinations. We categorized all cosmetic procedures into 3 groups based on body region. These groups were face (ie, blepharoplasty, brow lift, cheek implant, chin augmentation, facelift, facial resurfacing, hair replacement, otoplasty, rhinoplasty), breast (ie, augmentation, mastopexy, male breast surgery, reduction, revision breast implant procedures), and body (ie, abdominoplasty, brachioplasty, buttock lift, calf implant, labiaplasty, liposuction, lower body lift, thigh lift, upper body lift). Patients who underwent more than 1 cosmetic procedure under the same anesthetic were considered to have combined procedures. In addition, we looked at outcomes in each of the 24 surgical procedures performed as a solitary procedure to offset the potential effect modification from combining procedures.
Statistical Analysis
Two separate, deidentified, datasets were obtained from CosmetAssure, one with the enrollment data and other with claims information. The enrollment dataset contained entries for each unique procedure. Thus a patient undergoing combined procedures had separate entries for each procedure. A unique identifier was created using variables; date of birth, date of surgery, and BMI. Using this unique identifier, the enrollment dataset was restructured such that a patient undergoing combined procedures was counted once, with each of the procedures listed as a separate variable. Another unique identifier was created with variables shared between the enrollment and claims datasets; date of birth, date of surgery, and gender. This identifier was then used to match the claims dataset to the restructured enrollment dataset. Of the 2506 patients in the claims dataset, 20 did not match to the enrollment data using the identifier. These cases were manually matched to enrollee's with closest demographic characteristics. Kolmogorov-Smirnov statistic was used to check normal distribution of continuous variables (age and BMI). The only missing data were absent BMI information for 37 (0.7%) patients. These patients were included in the analysis without replacing these missing data points. Patient characteristics, risk factors, and complication rates between patients undergoing different procedure combinations were compared by two-tailed t test, Fisher exact test, or Pearson chisquare test. For the purpose of univariate analysis, age and BMI were recorded as ordinal variables with clinically appropriate categories. Standard logistic regression analysis was performed to identify the independent risk factors for postoperative complications. For the purpose of logistic regression analysis, age and BMI were recoded to a dichotomous scale (age ≥ 40 years/< 40 years, BMI ≥ 25/< 25). Outcomes were reported as 30-day incidence rates after the surgery. Unless otherwise noted, probability of type I error of less than 5% (P < 0.05) was used to determine statistical significance. All analyses were performed using IBM SPSS Statistics 23.0 software (IBM Corporation, Armonk, NY).
RESULTS
Between May 2008 and May 2013, a total of 183,914 aesthetic surgery procedures were performed on 129,007 patients that were enrolled in the CosmetAssure program. The mean age was 40.9 ± 13.9 years (range, 5-93 years), BMI 24.3 ± 4.4 kg/m 2 (range, 17.0-56.3 kg/m 2 ), and the majority of patients were women (93.5%). Major complications occurred in 2506 patients (1.9% complication rate). A total of 4978 rhinoplasties were performed, representing 3.86% of all 183,914 cosmetic surgeries. Of these, 3608 (72.5%) were performed as a single procedure, while 1370 (27.5%) were performed in conjunction with additional procedures, following a similar trend seen for other cosmetic surgical procedures.
Demographics
The rhinoplasty cohort consisted of 4229 females (85%) and 749 males (15%) with a mean age of 33.53 ± 13.42 years (range, 13-79 years) and a mean BMI of 22.75 ± 3.69 kg/m 2 (range, 17.0-54.9 kg/m 2 ). Compared to all cosmetic surgery procedures, the rhinoplasty cohort had a greater proportion of males (15.0% vs 6.1%, P < 0.01), and younger (age < 40 years) patients (69.5% vs 48.3%, P < 0.01). The rhinoplasty cohort had significantly less smokers (5.7% vs 8.3%, P < 0.01) and diabetics (0.7% vs 1.9%, P < 0.01), as well as significantly fewer patients with BMIs ≥25 kg/m 2 (22.0% vs 36.8%, P < 0.01). Similar to other cosmetic procedures, rhinoplasties were most commonly performed in ASCs (63.1%), followed by hospitals (25.7%) ( Table 1) .
Complications
Major complications occurred in 0.7% of patients in the rhinoplasty group (37 patients), compared to a 2.0% complication rate following all other cosmetic procedures ( Table 1) . Hematoma (n = 12) was the most common complication (0.2%), representing 32.4% of all complications. The second most common complication was surgical site infection (n = 9) (0.2%), representing 24.3% of all complications, followed by pulmonary complications (n = 7) with a complication rate of 0.1%, representing 18.9% of all complications. Suspected or confirmed VTE complications (n = 4) occurred with an incidence of 0.1%, representing 10.8% of all complications. Cardiac (n = 2), fluid overload (n = 2), and wound related complications (n = 1), represented 5.4%, 5.4%, and 2.7% of all complications, respectively ( Figure 1 ).
Risk Factors for Any Major Complication
On univariate analysis, age and combined procedures were the only risk factors associated with major complications. Age ≥40 years was associated with a significantly greater risk for major complications compared to age <40 years (1.3% vs 0.5%, P = 0.01) (Figure 2 ). Combined procedures increased the overall risk for any major complication from 0.6% to 1.2% (P = 0.04) (Figure 3 ). Patients with BMI ≥25 kg/m 2 had a greater incidence of major complications (1.1% vs 0.6%, P = 0.10), but this difference was not significant. The incidence of major complications in smokers compared to nonsmokers was also not significant (0.4% vs 0.8%, P = 0.43). Operation in a hospital-based setting compared to an OBSS was associated with a higher complication rate (1.0% vs 0.5%), although this increase was also not statistically significant (P = 0.40) (Figure 4 ). On multivariate logistic regression, age ≥40 years was the only independent risk factor (P < 0.05) for any major complication with a relative risk (RR) of 2.05 (P = 0.04, 95% confidence interval [1.02, 4.15]). Gender, BMI ≥25, smoking, and type of facility were not significant predictors for major complications (Table 2) . There were 37 patients in our series with diabetes mellitus and none of these patients developed major complications.
Risk Factors for Hematoma, Surgical Site Infection, and Pulmonary-Related Complications
We performed additional analysis to elucidate risk factors for the 3 most common complications: hematomas, surgical site infections, and pulmonary-related complications. On multivariate logistic regression analysis, combined procedures was found to be the only independent risk factor for development of hematomas (RR 3.38, P = 0.03) and pulmonary complications (RR 7.0, P = 0.03), but was not a risk factor for infectious complications (RR 1.10, P = 0.90) ( Tables 3-5) .
Combined Procedures
We assessed whether the number of additional operative procedures combined with rhinoplasty had an effect on the risk of complications. The demographical features of patients undergoing rhinoplasty alone and with combined procedures is demonstrated in Table 6 . The incidence of complications significantly increased from 0.58% in rhinoplasty alone to 1.02% (P < 0.05) in cases including rhinoplasty with one additional body region. The incidence of complications more than doubled to 2.09% (P < 0.05) in cases including 2 or more additional regions ( Figure 5 ). Univariate analysis revealed that the incidence of pulmonary-related complications increased significantly with the addition of operative procedures on additional body regions: rhinoplasty alone compared to rhinoplasty combined with one body region, from 0.1% to 0.3%, (P < 0.05), and rhinoplasty combined with two other body regions, from 0.1% to 1.0% (P < 0.05), an increased risk of 10-fold ( Figure 6 ).
We analyzed the trends in types of procedures most commonly performed with rhinoplasty. The most common combination included rhinoplasty with another face procedure in 11.6% of patients, followed by rhinoplasty with a breast procedure in 7.3% of patients (Table 7) . Breast augmentation, liposuction, and blepharoplasty were the most common additional surgeries (Figure 7) . We also noticed that in the age <40 years group, a significantly larger proportion of patients underwent rhinoplasty alone compared to a combined procedure (77.1% vs 49.7%, P < 0.01) (Figure 3 ).
Rhinoplasty Patient Profile Over 5 Years
Between 2008 and 2013, the proportion of patients undergoing rhinoplasty decreased from 4.1% to 3.4% (P < 0.01). There was a significant decrease in the number of smokers from 8.1% to 4.5% (P < 0.01). There was also a significant increase in rhinoplasties done in ASCs from 55.8% to 63.6% with a corresponding decreased use of OBSS and hospital settings (P < 0.01) (Figures 8, 9 ). 
DISCUSSION
This study represents the largest single database series of rhinoplasty patients published to date. Multiple articles delineate upon the untoward aesthetic and functional complications that ensue following rhinoplasty. Data on major disabling and life threatening complications postrhinoplasty are scant, however, mostly because the inherent risk for major complications following rhinoplasty is low. In our study of 4978 patients, the incidence of major complications was very low, 0.7% (n = 37). The incidence of significant complications in other studies has ranged from 1.7% to 18%. 3,10-15 Our considerably lower incidence can be attributed to several reasons. Most importantly, it has to be noted that this study captures only major complications requiring an emergency room visit, a hospital admission, or a reoperation, and are limited to events occurring within the first 30 postoperative days. Thus, clinically significant complications such as a wound dehiscence or a small septal hematoma for which office-based management can suffice would not be captured in our dataset. Furthermore, aesthetic and functional complications, which typically are not managed within the first 30 days postoperatively, also are not captured in our dataset.
Rhinoplasty Complications
Hematoma, including epistaxis or septal hematoma, was found to be the most common major complication in our study, with an incidence of 0.2% (n = 12). This is consistent with current literature reporting epistaxis to be the most common complication following rhinoplasty, with serious bleeding occurring in less than 1% of patients. 18 Counseling patients about this possibility and its sequelae is critical as it can affect the postoperative course as well as the aesthetic and functional outcome of the operation. The most common causes of epistaxis are bleeding from traumatized mucosa and incisions sites. 18, 19 Mild postoperative bleeding is controlled with head elevation, nostril pressure, and application of topical nasal decongestants. 18 If conservative measures fail, focal areas of bleeding can be cauterized and hemostatic packing can be placed; administration of desmopressin acetate (DDAVP) can be considered. 20, 21 Bleeding that persists despite anterior packing may be secondary to trauma to a branch of the sphenopalatine artery, requiring posterior packing and observation for airway compromise. 18 When these measures fail, angiographic embolization or operative intervention is required. 18 All hematomas should be drained following rhinoplasty. 3 If not drained, nasal skin hematomas result in fibrosis which then leads to contour irregularities. Septal hematomas lead to cartilage necrosis and possible loss of dorsal support, leading to a saddle-nose deformity. 18 Patients present with an ecchymotic nasal septal mass, and may also have nasal obstruction, rhinorrhea, or fever. 18 Our very low incidence of hematoma and epistaxis is likely due to the fact that only cases which required an emergency room visit, reoperation, or a hospital admission were included in the dataset as major complications. Mild epistaxis or an early septal hematoma managed during a clinic visit would not have been recorded in our dataset as a complication. Infection was the second most common major complication, with an incidence of 0.2% (n = 9) in our series. Infection rates in the literature have been reported to be between 0% and 3%. [22] [23] [24] Infection can range from a mild cellulitis to a life-threatening brain abscess and meningitis. 19 Soft tissue cellulitis can be treated with systemic antibiotics and close observation. Suspected abscess requires drainage and can involve the dorsum, tip, or septum. 18 Septal abscess typically results after an inadequately treated septal hematoma. 18 Abscess drainage and intravenous antibiotics are required until resolution. An inadequately treated septal abscess can lead to cavernous sinus thrombosis, meningitis, or a brain abscess. 19 Toxic shock syndrome has been reported following prolonged use of nasal packing or splints; symptoms can include nausea, emesis, fever, tachycardia, and hypotension, requiring removal of the foreign material, intravenous antibiotics, and intensive care monitoring. 18 None of the risk factors we examined were found to be significant for infectious complications following rhinoplasty. Pulmonary complication was the third most common, with an incidence of 0.1% (n = 7). In our dataset, pulmonary complications do not include DVT/pulmonary embolus or pneumonia, which were identified by CosmetAssure as claims separate and different from pulmonary complications. Although we were unable to determine the exact nature of the seven pulmonary complications in our series, we can speculate that these may include dyspnea, aspiration pneumonitis, or pulmonary edema. Aspiration pneumonitis can occur from aspiration of gastric contents or blood. Negativepressure pulmonary edema (NPPE) after routine rhinoplasty is an overlooked perioperative complication but has been well described. [25] [26] [27] A review of the literature suggests that in healthy adults undergoing general anesthesia the incidence of NPPE is estimated to be between 0.05% and 0.1%. [28] [29] [30] Westreich et al report a total of 146 cases of adult NPPE, 12 of which involved only septoplasty and/or rhinoplasty (8.2%). 27 The currently accepted pathophysiologic mechanism for rhinoplasty-specific NPPE is laryngospasm caused by laryngeal irritation. 27 After laryngospasm, continued inspiration against a closed glottis creates a high negative intrathoracic pressure, which then increases venous return to the right heart and pulmonary arteries; this causes the accumulation of volume in the interstitial and alveolar spaces. 27 The most likely cause of laryngospasm is a glottis closure reflex secondary to superior laryngeal nerve (SLN) stimulation. 27 It is thought that SLN stimulation can occur from blood accumulation, throat pack manipulation, suctioning prior to extubation, and from intubation. It is likely that, not one event, but multiple stimuli at intubation or extubation stimulate the SLN reflex. 27 Diagnosis of NPPE is considered following the onset of respiratory distress after extubation. Onset is typically immediate, but a delayed presentation of up to 24 hours has been reported. 28 Hypoxemia, tachypnea, tachycardia, and crepitations on auscultation ensue. 30 Drooling of pink frothy sputum after rhinoplasty has also been reported. 26 Treatment involves continuous positive airway pressure or reintubation and mechanical ventilation with positive end-expiratory pressure (PEEP) in an intensive care unit. 27 The role of diuretics and steroids are controversial. 27 Chest radiographs are done at the onset and followed until resolution of radiographic findings. Most cases of NPPE resolve within 24 hours. Westreich et al report a mean number of hours of intubation of 11.75 hours with a range of 1 to 336 hours; mortality ranges from 10% to 40%. 27 Knowledge of this perioperative complication is crucial to early recognition and intervention, shortening the time to resolution, and improving overall safety for rhinoplasty patients. Prevention of NPPE can be improved with gentle throat pack placement as well as careful suctioning prior to throat pack removal, which helps prevent fluid and exudate from irritating the larynx. 27 Topical lidocaine has also been shown to help prevent laryngospasm. 27 Similar to hematoma and infectious complications, there is scant literature regarding risk factors for pulmonary complications following rhinoplasty. Westreich et al reported numerous potential risk factors for rhinoplasty-specific NPPE including age younger than 40 years, muscular body type, male gender, short thick neck, sensitive gag reflex, underlying cardiac anomalies, Malampotty 3 status, history of obstructive sleep apnea, and lack of laryngotracheal anesthesia or intravenous lidocaine during anesthesia. 27 In our analysis, we found age and gender not to be significant risk factors for pulmonary-related complications. However, we have demonstrated that combined procedures are associated with a higher risk of pulmonary complications following rhinoplasty. In relation to NPPE, this could be due to prolonged superior laryngeal nerve irritation predisposing to laryngospasm.
Venous thromboembolic complications occurred with an incidence of 0.1% (n = 4) in our study. There is little literature on VTE in the cosmetic patient population given the relatively healthier patient selection; however, it is generally accepted that body contouring procedures have higher rates of VTE, while facial aesthetic procedures have lower rates. [31] [32] [33] To our knowledge, there is no literature reporting VTE following rhinoplasty aside from one case report 34 which occurred in a genetically predisposed patient. The rate of VTE following other facial procedures such as rhytidectomy have been reported to range from 0.01% to 0.35%. [31] [32] [33] 
Risk Factors
Age as a risk factor for any type of surgical procedure has been controversial, often complicated by physiologic aging-related changes and underlying disease states. 35 In our study, patients older than 40 years of age had a relative risk of 2.01 for major complications. Previous literature has shown that increasing age is associated with particular nasal anatomic characteristics 36, 37 that mandate special attention during rhinoplasty to prevent complications. A drooping nasal tip complex, septal abnormalities, inferior turbinate hypertrophy, as well as internal nasal valve collapse secondary to downward migration and separation of the upper and lower lateral cartilages all contribute to functional nasal airway obstruction in the aging population 36 and can be exacerbated if not corrected during surgery. A more fragile mucoperichondrium makes it more difficult to atraumatically dissect without perforation; 36 this increases the risk of a septal perforation in the aging population. Furthermore, increased vessel fragility as well as associated hypertension increases the risk of severe epistaxis and hematoma in the older patient. 36 Lastly, a more brittle nasal pyramid predisposes to comminution during osteotomies, making outcomes less predictable. 36 Gender, obesity, smoking, and the type of the facility that the procedure was performed have been studied extensively in various surgical populations to determine their effects on postoperative complications but not as thoroughly in the aesthetic surgical population including rhinoplasty procedures. Our study examined these variables and did not find them to be significant risk factors for major complications after rhinoplasty. We were unable to analyze the effect of diabetes on rhinoplasty complications since there were only 37 patients with diabetes in our series, none of which had any reportable major complications. Specifically for infectious complications, our findings are consistent with other studies noting that gender and smoking do not significantly change the nasal flora or postoperative infection rates. 23 There have been many studies analyzing the effect of combined procedures on complications rates following various cosmetic surgeries with mixed results. To our knowledge, our study is the only one to analyze the effect of combined procedures on complications following rhinoplasty. We have shown that the majority of rhinoplasties (72.5%) were performed alone and that undergoing procedures in addition to rhinoplasty was a significant risk factor for major complications. The major complication rate increased from 0.58% with isolated rhinoplasty to 1.02% with one additional procedure on one body region to 2.09% with additional procedures on 2 or more body regions. Previous studies have examined the increased risk for complications with combined procedures and have shown that this may be attributed to increased anesthetic time as seen in other studies. 31, 38 The procedure duration time is not available in the CosmetAssure database, and thus we were unable to examine this association. Furthermore, it is important to note that it is unknown whether a major complication following a combined procedure was attributed to the rhinoplasty or to a different body site, which limits our interpretation of these results.
Strengths and Limitations
The CosmetAssure database has provided a unique overall contribution to our understanding of aesthetic surgery complications as well as to the current trends of procedures over the 5-year study period. This study pools multiple centers, including hospitals, ASCs, and OBSS, imparting broad generalizability to our findings. Furthermore, the data were prospectively collected, allowing for an accurate representation of the incidence of complications and risk factors. Unique insight provided by this database also includes distinguishing between combination procedures and the types of the combination procedures in patients receiving rhinoplasty.
A previous study has shown cross-validation of CosmetAssure data with the Tracking Operations and Outcomes for Plastic Surgeons (TOPS) database. 39 Since CosmetAssure offers significant incentive to a surgeon for reporting a complication, in the form of payment of the claim, this database offers major advantage over TOPS by potentially minimizing the underreporting of complications. In addition, the dataset is validated by similar patient profile as that reported by the American Society for Aesthetic Plastic Surgery (ASAPS). 5 The relative frequency of procedures is different as the ASAPS estimate reports are based on data not only from plastic surgeons, but also from otolaryngologists and dermatologists. CosmetAssure offers coverage across all 50 states in the United States. Even if CosmetAssure is more commonly used in certain regions of the country, this is unlikely to affect the effect size of risk factors, thus maintaining the internal validity of the study. The database goes a step further by establishing the minimum surgeon qualification (plastic surgeons who are certified or are candidates for certification by the ABPS), thus avoiding variability in complications attributable to the credentials of the healthcare provider. In today's age, when rhinoplasties and other cosmetic surgeries are being performed by a variety of healthcare providers, it is essential to demonstrate and compare outcomes of these providers with different board affiliations.
While the CosmetAssure database has many advantages, its limitations need to be addressed. The CosmetAssure database, while prospective in nature and representing a large cohort of rhinoplasty patients, is not used by all plastic surgeons in the United States. Furthermore, while the database provides insightful information into the type of the cosmetic procedure, it does not give details about the surgical techniques implemented for rhinoplasty; this can have a significant effect on the complication rates and outcomes of the procedure. There is a spectrum of rhinoplasty techniques from aesthetic to functional, with large variations in the invasiveness, length of procedure, and potential complications. A portion of the procedure may be covered under conventional medical insurance and, therefore, it is possible that a postoperative complication may have been covered by a different insurance provider. This could have resulted in an underreporting of major complications in the database.
Furthermore, the database does not account for other pre and perioperative interventions such as antibiotic prophylaxis, DVT precautions, bleeding risk, vitals status, intraoperative complications, surgery duration, and prior surgical history of the patient. It also does not account for a patient's comorbidities and medications that could impact their risk for developing complications. The database also does not allow us to detect minor complications that could be clinically significant since these are generally not reported as a claim to the insurance company. This includes complications such as seroma, wound breakdown, and cellulitis since these can be managed in the clinic and do not require hospitalization, emergency room visits, or another operative procedure. Furthermore, the database does not register complications occurring after 30 days of the procedure, thus long term data of outcomes and complications are not available. Also, as already noted, it is not possible to decipher whether a major complication was secondary to the rhinoplasty portion of a combined procedure or to a different body site using the database information. Finally, patient-reported outcomes and satisfaction surveys are not documented throughout the database making perceived aesthetic and satisfaction outcomes unknown. This is important as patient satisfaction is the predominant consideration in determining success in aesthetic surgery.
CONCLUSIONS
The major complication rate following rhinoplasty remains low (0.7%). The risk is increased with age greater than 40 years and with the addition of other cosmetic procedures. Gender, type of facility, smoking status, and BMI >25 kg/m 2 had no significant effect on major complications. Pulmonary complications, although rare, do occur, and also increase when combining rhinoplasty with other aesthetic surgery. These findings are important to consider when planning rhinoplasty and educating patients on the safety of combined aesthetic surgeries.
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